Reconfiguration of private capital in the US healthcare sector
A simultaneous wave of take-privates, spin-offs and divestitures runs through the US healthcare sector: CVS dismantles its $117 billion vertical integration under regulatory pressure on PBMs and insurers, while Bon Secours, McKesson, BlackRock and Stryker absorb ambulatory surgery, primary care clinic and device assets. The dynamic underlies that upstream political and antitrust pressure forces the disintegration of conglomerates, and private capital —including non-PE capital such as BlackRock— recomposes the ownership of care infrastructure, with material consequences for prices, access and provider concentration.
Title, thesis and gravity assessment written by an AI model, without prior human review.
CVS announces the separation of its pharmacy and insurance business for $117 billion and simultaneously the take-privates of Surgery Partners ($5.7B) and Option Care ($5.8B) by Bon Secours, McKesson and CD&R are completed, reordering ownership and concentration in U.S. care infrastructure.
- Coverage
- 6 feeds · 6 independent publisher groups (corroborated)
- Cross verticals
- Geopolitics, Investing, Lifespan & Healthspan
- Tier 1 actors
- BlackRock
- Gravity vs. the previous edition
- no change (82)
coverage, not accuracy
- 23:09
- 18:30
- 17:23Stryker to invest $400m in CMR Surgical, with option to buy it outright · Sifted (European startups)
- 22:25
- 20:55
- 15:34
- 17:40
- 22:54
- 17:31
- 23:33CVS Health moves to dismantle $117bn healthcare empire · Financial Times
- 23:42
- 17:30
- 22:36
- 22:49
- 0European and Japanese space exploration of the deep solar system
- 82Pharmaceutical agreements between China and the West and R&D relocation
- 82Attacks with AI agents and regulatory response in Asia
- 80Industrial software acquisition by European energy conglomerates
- 80Binance security breach and insurer scrutiny of crypto exchanges